News

  • Interview with Executive Director and Head of R&D - EU regulatory update and analysis of FM57

    Ken James speaks to Proactive Investor’s Andrew Scott following positive initial discussions with EU regulators after an extensive internal evaluation of the clinical data from the Phase 3 study (“FM57”).

View more videos


Read more News

RNS


Read more RNS

Alert service

Our email news alert service provides a subscription to the RNS news from Futura Medical.

Sign up to our Alert Service

Latest videos

  • Interview with Executive Director and Head of R&D - EU regulatory update and analysis of FM57

    Interview with Executive Director and Head of R&D - EU regulatory update and analysis of FM57

  • Interview with Executive Director and Head of R&D - Phase III Results

    Interview with Executive Director and Head of R&D - Phase III Results

View more videos